← Eichor
Study identifier: NCT07180316 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of the Occurrence of Postoperative Complications Between Robotic and Laparoscopic Surgery in Revision Bariatric Surgery

Condition: Obesity and Overweight · Bariatric Surgery  ·  Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

In a population of patients undergoing bariatric revision surgery with conversion to RYGB and divided into two groups according to the surgical protocol: Group 1: robotic surgery Group 2: laparoscopy The primary objective of the study is to compare the rates of postoperative complications between the two groups, classified according to the Clavien Dindo classification. The secondary objectives are to compare between the groups: * Total duration of the surgical procedure, stay in the emergency room, and hospitalization * Postoperative pain * Adverse events * Weight loss * Improvement in comorbidities

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (2)

Hôpital Privé Jean MermozLyon, FranceRecruiting
Hôpital privé de la Loire - Ramsay SantéSaint-Etienne, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07180316